Multicentre Prospective Clinical Database for the Construction of Predictive Models on Risk of Intrauterine Adhesion
NCT ID: NCT05381376
Last Updated: 2022-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2200 participants
OBSERVATIONAL
2018-01-20
2024-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Chronic Endometritis in Postoperative Recurrence of Severe Intrauterine Adhesions
NCT02744807
Prospective Validation Study of a Uterine Fibroid-Related Infertility Prediction Model
NCT07177534
Efficacy of Estrogen-intrauterine Stent System After Intrauterine Adhesiolysis
NCT04972032
Establishment and Application of Endometrial 3D-organoid in Endometrial Injury Repair
NCT05521932
Clinical Study on a Novel Anti-adhesion Barrier Film
NCT05888545
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hysteroscopy
Hysteroscopy for CSGE, AFS, and endometrial receptivity assessment
Ultrasonography
Ultrasonography for Uterus size and endometrial thickness
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Desiring to conceive
* Ages between 20-45 years;
* Patients without gynecological endocrine disorders (e.g. PCOS) and AMH\>1ng/ml;
* Signing informed consent.
Exclusion Criteria
* Hormone therapy contraindications;
* Pregnancy contraindications;
* History of malignant pelvic tumor and radiotherapy;
* Severe hepatic or renal dysfunction;
* Complicated with hematological disorders (eg.platelet dysfunction, severe anemia, blood-borne infections);
* Male factor infertility(eg.seminal abnormalities).
20 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hua Duan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hua Duan
Director of Minimally Invasive Gynecologic Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yishaofu Hospital
Hangzhou, Zhejiang, China
Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IUADB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.